MOLECULAR DIVERSITY
Scope & Guideline
Fostering Excellence in Molecular Research Since 1995
Introduction
Aims and Scopes
- Synthetic Chemistry:
The journal publishes extensive research on novel synthetic methodologies, including multi-component reactions, green chemistry approaches, and environmentally benign synthesis techniques. This includes the development of new reactions and catalysts aimed at improving the efficiency and sustainability of chemical processes. - Medicinal Chemistry:
Research articles often focus on the design, synthesis, and evaluation of new pharmaceutical compounds, particularly those targeting diseases such as cancer, tuberculosis, and viral infections. This includes structure-activity relationship (SAR) studies and the exploration of molecular mechanisms of action. - Computational Chemistry and Molecular Modeling:
The integration of computational methods, including molecular docking, molecular dynamics simulations, and quantitative structure-activity relationship (QSAR) modeling, is a prominent feature. This approach aids in understanding molecular interactions and predicting the activity of new compounds. - Natural Products and Pharmacognosy:
The journal highlights studies that investigate the bioactive potential of natural products and their derivatives, focusing on their roles as lead compounds in drug discovery. Research often involves isolation, characterization, and evaluation of pharmacological activities. - Targeted Drug Design and Repurposing:
A significant emphasis is placed on the design and identification of inhibitors targeting specific proteins involved in disease pathways, including drug repurposing strategies that utilize existing compounds for new therapeutic applications.
Trending and Emerging
- Artificial Intelligence and Machine Learning in Drug Discovery:
There is an increasing incorporation of AI and machine learning techniques to facilitate drug discovery processes. This includes predictive modeling for bioactivity, virtual screening, and optimizing synthetic routes, which represents a significant trend in modern medicinal chemistry. - Focus on Viral Infections:
Research targeting viral infections, particularly those related to COVID-19, has surged. This includes studies on drug repurposing, the design of antiviral agents, and understanding viral mechanisms, reflecting an urgent response to global health challenges. - Network Pharmacology:
The application of network pharmacology is gaining traction, emphasizing the understanding of complex biological interactions and pathways. This approach aids in identifying potential therapeutic targets and understanding the multi-target effects of compounds. - Sustainable and Green Chemistry Practices:
There is a marked increase in studies emphasizing sustainable synthesis and environmentally friendly methodologies. Researchers are focusing on reducing the environmental impact of chemical processes through innovative synthetic strategies. - Natural Product Derivatives:
The exploration of natural product derivatives continues to rise, particularly in the context of drug discovery. This includes the synthesis and evaluation of compounds derived from plants and marine sources, which are being investigated for their therapeutic potential.
Declining or Waning
- Traditional Synthetic Methods:
There is a noticeable decrease in studies focusing solely on conventional synthetic methods without the integration of advanced techniques or green chemistry principles. The trend is moving towards more innovative and sustainable approaches. - Basic Pharmacological Studies:
The journal has seen fewer articles that solely present basic pharmacological studies without a strong emphasis on molecular mechanisms or computational analysis. Research is increasingly expected to provide deeper insights into the mechanistic aspects of drug action. - Broad-Spectrum Antibacterial Agents:
Research on broad-spectrum antibacterial agents has become less frequent as the focus shifts towards more targeted therapies that address specific bacterial mechanisms of resistance, particularly in the context of rising antibiotic resistance. - Non-Computational Approaches:
There appears to be a decline in the publication of studies that do not incorporate computational methods. The integration of computational analyses is becoming a standard expectation in research, leading to fewer standalone experimental studies.
Similar Journals
REVUE ROUMAINE DE CHIMIE
Catalyzing Innovation in the Realm of ChemistryREVUE ROUMAINE DE CHIMIE is a distinguished academic journal in the field of chemistry, published by EDITURA ACAD ROMANE in Romania. With an ISSN of 0035-3930, this journal has been a valuable platform for disseminating original research and insights in the diverse realm of chemistry since its inception. The journal currently operates under a competitive tier, categorized in Q4 for miscellaneous chemistry fields, as reflected in its Scopus ranking of #348 out of 408, placing it within the 14th percentile. Aiming to foster scientific discourse and innovation, the REVUE ROUMAINE DE CHIMIE provides a repository of knowledge that is crucial for researchers, professionals, and students eager to advance their understanding and contribute to the global chemistry community. By bridging local and international research initiatives, this journal plays an essential role in enhancing the visibility of Romanian scientific contributions on the world stage.
SynOpen
Exploring the Frontiers of Materials ScienceSynOpen is an esteemed open-access journal published by GEORG THIEME VERLAG KG, based in Germany, dedicated to advancing the fields of Biomaterials, Catalysis, Materials Science, and Organic Chemistry. Since its inception in 2017, the journal has established itself as a vital platform for researchers wishing to disseminate their findings in a rapidly evolving scientific landscape, earning a commendable Q2 ranking in Materials Science (miscellaneous) and Q3 in other key categories for 2023. With an increasing impact on its disciplines, SynOpen aims to foster interdisciplinary collaboration and innovation by providing unrestricted access to high-quality research, thus promoting a broader reach and visibility for authors. Scholars, professionals, and students alike can benefit from the comprehensive range of topics covered, as the journal's commitment to presenting cutting-edge studies and methodologies positions it as a crucial resource for contemporary scientific inquiry.
Jordan Journal of Chemistry
Empowering Researchers: Unlocking the Potential of Chemistry in Jordan.The Jordan Journal of Chemistry is a prominent publication dedicated to advancing the field of chemistry in Jordan and beyond. Published by the Yarmouk University Deanship of Research & Graduate Studies, this journal serves as a platform for researchers, educators, and practitioners to disseminate their findings in a variety of chemistry sub-disciplines. Although currently classified in Q4 of miscellaneous chemistry and ranking within the 9th percentile according to Scopus, the journal plays a crucial role in fostering academic dialogue and collaboration in the region. With its ISSN 1814-9111 and E-ISSN 2079-7249, the Jordan Journal of Chemistry offers open access to researchers from diverse backgrounds, ensuring that critical research is both accessible and impactful. By bridging local studies with global scientific advancements, this journal is poised to contribute significantly to the growth and recognition of chemistry as a key scientific discipline in the region, with convergence efforts set from 2020 to 2024.
BIOORGANIC & MEDICINAL CHEMISTRY
Innovating Drug Discovery Through ChemistryBIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.
LETTERS IN ORGANIC CHEMISTRY
Bridging Research and Practice in Organic ChemistryLETTERS IN ORGANIC CHEMISTRY is a distinguished journal published by Bentham Science Publishers Ltd, focusing on the rapidly evolving field of organic chemistry. Established in 2005, the journal commits itself to disseminating vital research findings, reviews, and innovative methodologies that contribute to the understanding and advancement of organic chemistry and biochemistry. With an ISSN of 1570-1786 and an E-ISSN of 1875-6255, this journal enhances accessibility and visibility for authors and readers alike, albeit not adopting an open-access model. Positioned within Q4 quartile rankings for both Biochemistry and Organic Chemistry, it serves a niche audience keen on exploring emerging trends and breakthroughs in these disciplines. Its Scopus rankings further reflect its role in the global academic landscape, albeit at the beginning stages of its impact journey. Based in the United Arab Emirates, LETTERS IN ORGANIC CHEMISTRY is dedicated to fostering dialogue among researchers and practitioners, paving the way for future innovations in organic and biochemical sciences.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Exploring breakthroughs in bioorganic science.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.
CURRENT MEDICINAL CHEMISTRY
Illuminating Pathways in Organic Chemistry and Pharmacology.Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.
Chemical Biology & Drug Design
Pioneering the intersection of chemistry and medicine for a healthier future.Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.
ACS Bio & Med Chem Au
Pioneering interdisciplinary studies that shape the future of medicine.ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.
SYNTHESIS-STUTTGART
Exploring the Depths of Organic Chemistry Excellence.SYNTHESIS-STUTTGART
Published by the esteemed Georg Thieme Verlag KG, SYNTHESIS-STUTTGART stands as a vital resource in the field of Chemistry, specifically focusing on Organic Chemistry and Catalysis. With an impressive publication history dating back to 1970 and continuing through 2024, it serves as a platform for innovative research and developments in synthetic methodologies and their applications. The journal holds a significant impact factor, reflecting its influence within the academic community, and is recognized in the Scopus rankings as a reputable source in its categories, with a rank of #99/211 in Organic Chemistry and #43/68 in Catalysis. Researchers, professionals, and students alike can benefit greatly from its content, which upholds rigorous peer-review standards and contributes to the global discourse in these critical scientific domains.